FDA Approves First Pill to Treat Severe Alopecia Areata
TUESDAY, June 14, 2022 -- The first pill to treat adults with severe alopecia areata was approved by the U.S. Food and Drug Administration on Monday. Olumiant (baricitinib) is the first FDA-approved alopecia therapy that treats the entire body... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2022 Category: Pharmaceuticals Source Type: news

F.D.A. Approves Alopecia Drug That Restores Hair Growth in Many Patients
The drug, made by Eli Lilly, is already used for rheumatoid arthritis, and could be followed by two more drugs from other companies. (Source: NYT Health)
Source: NYT Health - June 13, 2022 Category: Consumer Health News Authors: Gina Kolata Tags: your-feed-science Alopecia Areata Eli Lilly and Company Food and Drug Administration Source Type: news

FDA approves alopecia areata treatment with roots at Yale
In a Q&A, Brett King discusses the FDA ’s announcement of the drug baricitinib as the first-ever approved treatment for the autoimmune disorder alopecia areata. (Source: Yale Science and Health News)
Source: Yale Science and Health News - June 13, 2022 Category: Universities & Medical Training Source Type: news

FDA OKs First Systemic Treatment for Alopecia Areata FDA OKs First Systemic Treatment for Alopecia Areata
Baricitinib, a JAK inhibitor, is now approved for the treatment of adults with severe AA. The disease affects more than 300,000 people in the US every year.FDA Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 13, 2022 Category: Allergy & Immunology Tags: Dermatology News Alert Source Type: news

FDA Approves First Systemic Treatment for Alopecia Areata
(MedPage Today) -- The FDA approved the Janus kinase (JAK) inhibitor baricitinib (Olumiant) as the first systemic treatment for alopecia areata. The approval pertains to adults with severe alopecia areata, which affects more than 300,000 people... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 13, 2022 Category: American Health Source Type: news

FDA approves first systemic treatment for alopecia areata
Today, the U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a disorder that often appears as patchy baldness and affects more than 300,000 people in the U.S. each year. Today's action marks the first FDA approval of a systemic treatment (i.e. treats the entire body rather than a specific location) for alopecia areata. (Source: World Pharma News)
Source: World Pharma News - June 13, 2022 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

FDA Approves Lilly and Incyte's Olumiant (baricitinib) as First and Only Systemic Medicine for Adults with Severe Alopecia Areata
INDIANAPOLIS, June 13, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) has approved Olumiant (baricitinib), a once-daily pill, as a first-in-disease... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 13, 2022 Category: Drugs & Pharmacology Source Type: news

What causes alopecia, a 'devastating' hair loss condition affecting Jada Pinkett Smith
Alopecia areata is the condition affecting Jada Pinkett Smith, who found herself at the center of the Will Smith-Chris Rock conflict at the Oscars ceremony March 27. Dr. Brett King answers FAQs about the causes, severity, challenges, treatments and more. (Source: CNN.com - Health)
Source: CNN.com - Health - June 1, 2022 Category: Consumer Health News Source Type: news

Pinkett Smith talks hair-loss 'shame,' outcome of Oscar slap - The Associated Press
LOS ANGELES — Jada Pinkett Smith turned her husband's Oscar-night blowup into a teachable moment about alopecia areata, the hair-loss disorder affecting her and millions of others that, in some... #jadapinkettsmith #hairloss #theassociatedpress (Source: Reuters: Health)
Source: Reuters: Health - June 1, 2022 Category: Consumer Health News Source Type: news

Arthritis treatment which can help patients with alopecia
One baricitinib success story is Tracy Watkins, 53, from North London, who has been taking it daily since her diagnosis of alopecia areata in May 2019. (Source: the Mail online | Health)
Source: the Mail online | Health - May 28, 2022 Category: Consumer Health News Source Type: news

Alopecia drug regrows hair in 40% of patients with condition suffered by Jada Pinkett-Smith
A Yale University, Connecticut, study of the twice-a-day pill found four in 10 patients with alopecia areata were able to regrow nearly a full head of hair within half a year. (Source: the Mail online | Health)
Source: the Mail online | Health - May 25, 2022 Category: Consumer Health News Source Type: news

Baricitinib Backed for Approval for Alopecia Areata in the EU Baricitinib Backed for Approval for Alopecia Areata in the EU
In February 2022, the FDA granted priority review for baricitinib in adults with severe alopecia areata.International Approvals (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - May 20, 2022 Category: Internal Medicine Tags: Dermatology News Alert Source Type: news

Baricitinib Promotes Hair Growth in Alopecia Areata Baricitinib Promotes Hair Growth in Alopecia Areata
More than one third of patients who received the high dose of the Janus kinase inhibitor achieved the study goal of approximately 80% hair coverage.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 12, 2022 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

Alopecia Areata: What you need to know
Alopecia Areata is an autoimmune disorder that leads to loss of hair in clumps or patches. (Source: The Economic Times)
Source: The Economic Times - April 18, 2022 Category: Consumer Health News Source Type: news

What you should know about alopecia, the hair loss condition affecting Jada Pinkett Smith
Alopecia areata is the condition affecting Jada Pinkett Smith, who found herself at the center of the Will Smith-Chris Rock conflict at the Oscars ceremony Sunday. Dr. Brett King answers FAQs about the causes, severity, challenges, treatments and more. (Source: CNN.com - Health)
Source: CNN.com - Health - March 29, 2022 Category: Consumer Health News Source Type: news